The efficacy and safety of Erbium:YAG laser for treatment of enlarged pores: a pilot study
Not Applicable
Completed
- Conditions
- enlarged poreErbium:YAG laser
- Registration Number
- TCTR20170410001
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 19
Inclusion Criteria
patient with enlarged pores at nose and cheeks
Exclusion Criteria
-patient with photosensitivity, acne, infection or inflammation at the study area
-smoking
-pregnancy and lactation
-using any product contain AHA or retinoic acid within 6 months prior to the study period
-treated with any laser or radiofrequency within 6 months prior to the study period
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method efficacy of Erbium:YAG laser for treatment of enlarged pores 1 month after 5th treatment, 3 months after 5th treatment, 6 months after 5th treatment pore size measured by UVA-light video camera
- Secondary Outcome Measures
Name Time Method side effect of Erbium:YAG laser for treatment of enlarged pores immediate after treatment, months after 5th treatment, 6 months after 5th treatment physician assessment